Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation

被引:100
作者
Kaye, JF [1 ]
Lever, AML [1 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
关键词
D O I
10.1128/JVI.72.7.5877-5885.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability of human immunodeficiency virus types 1 (HIV-1) and 2 (HIV-2) to cross-package each other's RNA was investigated by cotransfecting helper virus constructs with vectors derived from both viruses from which the gag and pal sequences had been removed. HIV-1 was able to package both HIV-1 and HIV-2 vector RNA. The unspliced HIV-1 vector RNA was packaged preferentially over spliced RNA; however, unspliced and spliced HIV-2 vector RNA were packaged in proportion to their cytoplasmic concentrations. The HIV-2 helper virus was unable to package the HIV-1 vector RNA, indicating a nonreciprocal RNA packaging relationship between these two lentiviruses. Chimeric proviruses based on HIV-2 were constructed to identify the regions of the HIV-1 Gag protein conferring RNA-packaging specificity for the HIV-1 packaging signal. Two chimeric viruses were constructed in which domains within the HIV-2 gag gene were replaced by the corresponding domains in HIV-1, and the ability of the chimeric proviruses to encapsidate an HN-l-based vector was studied. Wild-type HIV-2 was unable to package the HIV-1-based vector; however, replacement of the HIV-2 nucleocapsid by that of HIV-1 generated a virus with normal protein processing which could package the HIV-1-based vector. The chimeric viruses retained the ability to package HIV-2 genomic RNA, providing further evidence for a lack of reciprocity in RNA-packaging ability between the HIV-1 and HIV-2 nucleocapsid proteins, Inclusion of the p2 domain of HIV-1 Gag in the chimera significantly enhanced packaging.
引用
收藏
页码:5877 / 5885
页数:9
相关论文
共 47 条
[1]   MUTATIONS OF RNA AND PROTEIN SEQUENCES INVOLVED IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PACKAGING RESULT IN PRODUCTION OF NONINFECTIOUS VIRUS [J].
ALDOVINI, A ;
YOUNG, RA .
JOURNAL OF VIROLOGY, 1990, 64 (05) :1920-1926
[2]   Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: A new approach to gene therapy of HIV infection [J].
Arya, SK ;
Gallo, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4486-4491
[3]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 LONG TERMINAL REPEAT - ANALYSIS OF REGULATORY ELEMENTS [J].
ARYA, SK ;
GALLO, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (24) :9753-9757
[4]  
Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1
[5]   EFFICIENT TRANSACTIVATION BY THE HIV-2 TAT PROTEIN REQUIRES A DUPLICATED TAR RNA STRUCTURE [J].
BERKHOUT, B ;
GATIGNOL, A ;
SILVER, J ;
JEANG, KT .
NUCLEIC ACIDS RESEARCH, 1990, 18 (07) :1839-1846
[6]   RETROVIRAL NUCLEOCAPSID DOMAINS MEDIATE THE SPECIFIC RECOGNITION OF GENOMIC VIRAL RNAS BY CHIMERIC GAG POLYPROTEINS DURING RNA PACKAGING IN-VIVO [J].
BERKOWITZ, RD ;
OHAGEN, A ;
HOGLUND, S ;
GOFF, SP .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6445-6456
[7]   SPECIFIC BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG POLYPROTEIN AND NUCLEOCAPSID PROTEIN TO VIRAL RNAS DETECTED BY RNA MOBILITY SHIFT ASSAYS [J].
BERKOWITZ, RD ;
LUBAN, J ;
GOFF, SP .
JOURNAL OF VIROLOGY, 1993, 67 (12) :7190-7200
[8]   ANALYSIS OF BINDING-ELEMENTS IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GENOMIC RNA AND NUCLEOCAPSID PROTEIN [J].
BERKOWITZ, RD ;
GOFF, SP .
VIROLOGY, 1994, 202 (01) :233-246
[9]  
CLACKSON T, 1991, PCR PRACTICAL APPROA, P204
[10]   A MUTANT OF HUMAN-IMMUNODEFICIENCY-VIRUS WITH REDUCED RNA PACKAGING AND ABNORMAL PARTICLE MORPHOLOGY [J].
CLAVEL, F ;
ORENSTEIN, JM .
JOURNAL OF VIROLOGY, 1990, 64 (10) :5230-5234